49 POSITIVE NMP22 AND ABSENCE OF EVIDENT UROLOGICAL DISEASE IN PATIENTS FOLLOWED FOR NON-MUSCLE INVASIVE BLADDER CANCER (NMI-BC). LONG TERM OUTCOME